Cargando…
Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus
Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive d...
Autor principal: | Mohapatra, Satyakam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857859/ https://www.ncbi.nlm.nih.gov/pubmed/27121435 http://dx.doi.org/10.9758/cpn.2016.14.2.218 |
Ejemplares similares
-
Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009) -
The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report
por: Haile, Kibrom, et al.
Publicado: (2019) -
Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report
por: Guo, Xiaoling, et al.
Publicado: (2023) -
Effect of Quetiapine in young schizophrenic patients with tardive dyskinesia
por: Singh, Piyush, et al.
Publicado: (2010) -
Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression
por: Hou, Yi-Cheng, et al.
Publicado: (2014)